Mood Disorder.
Sekhon S, Gupta V.
2023 May 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Transcranial Direct Current Stimulation vs Sham for the Treatment of Inattention in Adults With Attention-Deficit/Hyperactivity Disorder: The TUNED Randomized Clinical Trial.
Leffa DT, Grevet EH, Bau CHD, Schneider M, Ferrazza CP, da Silva RF, Miranda MS, Picon F, Teche SP, Sanches P, Pereira D, Rubia K, Brunoni AR, Camprodon JA, Caumo W, Rohde LA.
JAMA Psychiatry. 2022 Sep 1;79(9):847-856. doi: 10.1001/jamapsychiatry.2022.2055.
Prevalence of cognitive impairment in major depression and bipolar disorder.
Douglas KM, Gallagher P, Robinson LJ, Carter JD, McIntosh VV, Frampton CM, Watson S, Young AH, Ferrier IN, Porter RJ.
Bipolar Disord. 2018 May;20(3):260-274. doi: 10.1111/bdi.12602. Epub 2018 Jan 18.
EEG alpha band characteristics in patients with a depressive episode within recurrent and bipolar depression.
Bokhan NA, Galkin SA, Vasilyeva SN.
Consort Psychiatr. 2023 Sep 29;4(3):5-12. doi: 10.17816/CP6140.
Epidemiology of bipolar disorders.
Bauer M, Pfennig A.
Epilepsia. 2005;46 Suppl 4:8-13. doi: 10.1111/j.1528-1167.2005.463003.x.
Bipolar Disorder: an impossible diagnosis.
Faravelli C, Gorini Amedei S, Scarpato MA, Faravelli L.
Clin Pract Epidemiol Ment Health. 2009 Jun 16;5:13. doi: 10.1186/1745-0179-5-13.
Pharmacokinetic evaluation of armodafinil for the treatment of bipolar depression.
Niemegeers P, Maudens KE, Morrens M, Patteet L, Joos L, Neels H, Sabbe BG.
Expert Opin Drug Metab Toxicol. 2012 Sep;8(9):1189-97. doi: 10.1517/17425255.2012.708338. Epub 2012 Jul 18.
The relationship between inflammatory state and quantity of affective episodes in bipolar disorder.
Queissner R, Pilz R, Dalkner N, Birner A, Bengesser SA, Platzer M, Fellendorf FT, Kainzbauer N, Herzog-Eberhard S, Hamm C, Reininghaus B, Zelzer S, Mangge H, Mansur RB, McIntyre RS, Kapfhammer HP, Reininghaus EZ.
Psychoneuroendocrinology. 2018 Apr;90:61-67. doi: 10.1016/j.psyneuen.2018.01.024. Epub 2018 Feb 3.
Suicidality in patients with bipolar depression: Findings from a lower middle-income country.
Xue S, Hodsoll J, Khoso AB, Husain MO, Chaudhry IB, Young AH, Zaheer J, Husain N, Mulsant BH, Husain MI.
J Affect Disord. 2021 Jun 15;289:1-6. doi: 10.1016/j.jad.2021.04.015. Epub 2021 Apr 17.
Symptom modulation and tolerability of intravenous ketamine in treatment-resistant bipolar depression: A retrospective study.
Cuomo A, Pardossi S, Barillà G, Carmellini P, Firenzuoli B, Tarantino F, Tinturini R, Fagiolini A.
J Affect Disord. 2025 May 1;376:76-83. doi: 10.1016/j.jad.2025.01.059. Epub 2025 Feb 2.
